Equibolin By Hi-Tech Pharmaceuticals Overview & Drug Interactions

Check For Interactions With Equibolin

Supplement: Equibolin by Hi-Tech Pharmaceuticals

Equibolin Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Equibolin by Hi-Tech Pharmaceuticals

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Tablet(s)
Maximum serving Sizes:
1 Tablet(s)
Servings per container 60

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
3-Beta-Hydroxy-1,4-Androstadien-17-One Undecanoate, 17a-Hydroxy-Pregna-1,4-Diene-3,20-Dione
75 mg
Epindrosterone --
Rhaponticum carthamoides 100:1 extract
250 mg
Maral Root --

Other Ingredients:
Microcrystalline Cellulose
Phosphatidylcholine
Hydroxypropyl Beta Cyclodextrin
Phytosterols
Magnesium Stearate
Silica
FD&C Blue #2
FD&C Red #40


Label Statments:


Formulation
- Cyclosome Delivery Powerful Anabolic Agent Increase Protein Synthesis Increase Testosterone Increase Lean Muscle Gains
FDA Statement of Identity
- Dietary Supplement

Brand Information

See all products by this brand

Manufacturer
Name Hi-Tech Pharmaceuticals

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.